pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Experts warn splitting MMR vaccine into separate shots could increase missed doses and illness

Aug 11, 2026·read at STAT ↗RegulatoryNegative

The article notes that a recent executive order proposes separating the combined measles, mumps and rubella vaccine into three individual injections. The author argues that this change could lead to more children missing doses, raising the risk of disease outbreaks.

He cites the history of the MMR vaccine’s development, recalling how the original combined formulation was created after a child’s mumps infection was studied by a Merck scientist. The piece emphasizes that the combined shot has been proven safe and effective.

The author warns that forcing manufacturers to produce separate vaccines may create logistical challenges and reduce vaccination rates, ultimately harming public health.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “How we know that splitting up the MMR vaccine could be dangerous”

read at STAT ↗
1,135 words · retrieved 3h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING
topics
Vaccine19Vaccines14Breast CancerImmunologyInfectious DiseaseOncology

related stories

  • 3h agoAura, Schrödinger trim workforcesBioSpace
  • Dec 22Fierce Biotech Fundraising Tracker '26: Vaderis nets $152M series B; Epicrispr adds $90MFierce Biotech
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Apr 28Predicting consequences of new hepatitis B vaccine recsSTAT
  • Apr 27New U.S. recommendation on hepatitis B vaccine will have dire consequences, studies projectSTAT